智能体规范应用与创新发展实施意见
智能体规范应用与创新发展实施意见_中央网络安全和信息化委员会办公室
This implementation opinion provides guidance on the standardized application and innovative development of artificial intelligence agents. It outlines requirements for guiding the orderly growth, technical application, and governance standards of intelligent agents in relevant sectors. The document aims to promote technological advancement while ensuring safety and normative oversight.
Summary and content fields are drawn from the document text and are pending editorial review.
Who issued it
Who it governs
AI developers, deployers, and public sector regulators seeking guidance on intelligent agent policies in China.
What the document contains
The document addresses the regulation, standardized deployment, and innovative application paths for AI agents at the national level.
Detailed numerical metrics and technical source code implementations are not stated.
- The document focuses on the standardized application and innovative development of AI agents.
- It promotes orderly technical advancement and governance for intelligent systems.
- Issued by the Office of the Central Cyberspace Affairs Commission (CAC).
How it scores
Each score is backed by a quote verified against the document text. Editorial review has not yet confirmed them.
Accountability
0/5Clear responsibility for AI outcomes
N/A
screening score · 2026-10-24
Fairness
0/5Non-discrimination and equitable treatment
N/A
screening score · 2026-10-24
Human Dignity
0/5Respect for the inherent worth of persons
N/A
screening score · 2026-10-24
Human Oversight
0/5Humans remain in control of consequential decisions
N/A
screening score · 2026-10-24
Privacy
0/5Protection of personal data and private life
N/A
screening score · 2026-10-24
Transparency
0/5Openness about how AI systems work and are used
N/A
screening score · 2026-10-24
Enforcement
0/5Consequences and compliance mechanisms with real force
N/A
screening score · 2026-10-24
Impact Assessment
0/5Required assessment of an AI system's risks/impacts before or during use
N/A
screening score · 2026-10-24